We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study Links Saliva-Based Epigenetic Signals to OCD Treatment Outcomes

By LabMedica International staff writers
Posted on 20 Oct 2026

Obsessive-compulsive disorder (OCD) causes unwanted, recurring thoughts and repetitive behaviors that can severely disrupt daily life. More...

Exposure-based psychotherapy is among the most effective treatments, but the biological processes underlying treatment response remain poorly understood. Understanding these processes could help clarify why outcomes differ between individuals. New findings offer insight into this question, suggesting that epigenetic markers may be associated with how people with OCD respond to intensive psychotherapy.

Researchers from the University of Bergen (Bergen, Norway) studied DNA methylation in people with OCD receiving exposure-based psychotherapy. DNA methylation is an epigenetic mechanism in which small chemical groups attach to DNA and can influence gene activity without altering the genetic code. The work focused on whether methylation patterns were associated with response to the Bergen 4-Day Treatment, an intensive form of exposure-based psychotherapy.

The researchers analyzed saliva samples from approximately 900 people with OCD treated at eight clinics across Norway. Samples were collected before treatment, immediately after treatment, and at a three-month follow-up. This design allowed the investigators to examine both methylation patterns present before therapy and methylation changes occurring over time.

The study identified several DNA regions where methylation was associated with treatment response. Some differences were detectable before therapy or remained stable over time, with many showing strong genetic influences. Published in Neuropsychopharmacology, these findings suggest that certain epigenetic patterns may reflect relatively stable biological characteristics associated with how individuals respond to psychotherapy.

Changes in DNA methylation over time were also associated with treatment outcomes. Unlike the more stable methylation patterns, these changes showed no detectable genetic influences. They were also associated with other clinical factors, including medication use.

The identified methylation differences were located in or near genes involved in brain plasticity, stress responses, immune function, gene regulation, and cellular energy production. The findings highlight the potential of epigenetic markers to help predict individual responses to psychotherapy and support more personalized approaches to OCD treatment. However, the associations do not establish causal relationships, and further research is needed to determine whether these markers can reliably predict treatment outcomes in clinical practice.

Related Links
University of Bergen 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A blood test measuring circulating tumor DNA may help identify men with hormone-resistant oligoprogressive prostate cancer most likely to benefit from stereotactic body radiotherapy (Image Credit: Adobe Stock)

Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

Advanced prostate cancer can progress despite hormone-based treatment, with imaging sometimes revealing only limited areas of active disease. For men with hormone-resistant oligoprogressive prostate cancer,... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.